《大行報告》高盛上調農夫山泉(09633.HK)目標價至51元 評級「買入」
高盛發表報告指,農夫山泉(09633.HK)上半年錄24%的銷售增長,每股盈利錄30%增長,均較公司預期的高,相信是行業需求增長及市佔率上升所致。
該行指,農夫山泉上半年提供更吸引的推廣及銷售策略,並提供更多提高品牌的活動,相信有助市佔率繼續上升。預期水和茶的業務都會跑贏市場,當中只有功能性飲品因應競爭增加而與2019年有較大差距。新業務方面,梳打水飲品將是未來的發展重點,相信公司將會有優勢。
該行表示,升農夫山泉2021至2023年每股盈利5-6%,以反映上半年的表現,目標價由48元升至51元,此相當預測2026年市盈率40倍,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.